Contract development and manufacturing organization (CDMO) Capstone Development has announced that its biosimilar version of insulin has received marketing auth 30 November 2022
Novo Nordisk has announced plans to spend 5.4 billion Danish kroner ($750 million) on the expansion of existing facilities and the addition of a new plant in Ba 22 November 2022
Diabetes giant Novo Nordisk (NOV: N) looks set to maintain its dominant position in type 2 diabetes, despite recent supply issues affecting its glucagon-like pe 11 November 2022
German drugmaker Merck KGaA has reported net sales in the third quarter of 5.8 billion euros ($5.8 billion), in line with many analysts’ expectations, with earn 10 November 2022
A new prefilled autoinjector pen for diabetics, Ogluo (glucagon) has been launched in Germany by Tetris Pharma, a subsidiary of British firm Arecor Therapeutics 1 November 2022
Shares in Merck & Co were nearly 2% higher at lunchtime Thursday after the US pharma giant presented its third quarter financial results. 27 October 2022
Boston, Massachusetts-based nonprofit The Institute for Clinical and Economic Review (ICER) has issued its final report into the cost-effectiveness of the lates 21 October 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.